These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma. Hirata H, Okayama N, Naito K, Inoue R, Yoshihiro S, Matsuyama H, Suehiro Y, Hamanaka Y, Hinoda Y. Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295 [Abstract] [Full Text] [Related]
25. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Zhu Y, Spitz MR, Lei L, Mills GB, Wu X. Cancer Res; 2001 Nov 01; 61(21):7825-9. PubMed ID: 11691799 [Abstract] [Full Text] [Related]
26. A single-nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances bladder cancer susceptibility. Tasci AI, Tugcu V, Ozbek E, Ozbay B, Simsek A, Koksal V. BJU Int; 2008 Feb 01; 101(4):503-7. PubMed ID: 17986285 [Abstract] [Full Text] [Related]
27. A functional polymorphism (-1607 1G→2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer. Liu L, Wu J, Wu C, Wang Y, Zhong R, Zhang X, Tan W, Nie S, Miao X, Lin D. Cancer; 2011 Nov 15; 117(22):5172-81. PubMed ID: 21523769 [Abstract] [Full Text] [Related]
31. Association of MMP-1 -1607 1G/2G (rs1799750) polymorphism with primary knee osteoarthritis in the Greek population. Lepetsos P, Pampanos A, Kanavakis E, Tzetis M, Korres D, Papavassiliou AG, Efstathopoulos N. J Orthop Res; 2014 Sep 15; 32(9):1155-60. PubMed ID: 24838892 [Abstract] [Full Text] [Related]
32. Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies. Peng B, Cao L, Wang W, Xian L, Jiang D, Zhao J, Zhang Z, Wang X, Yu L. Mutagenesis; 2010 Jan 15; 25(1):41-8. PubMed ID: 19843588 [Abstract] [Full Text] [Related]
34. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M, Guagnellini E, Scorza R. Clin Cancer Res; 2002 Dec 15; 8(12):3820-3. PubMed ID: 12473595 [Abstract] [Full Text] [Related]
35. Examining the association of MMP-1 gene -1607 (2G/1G) and -519 (A/G) polymorphisms with the risk of osteomyelitis: A case-control study. Kong Q, Jin Y, Yan S, Wang Y, Zhao J, Feng Z, Wei J, Wang Y, Kong L, Guo L, Yang J. Medicine (Baltimore); 2017 Oct 15; 96(42):e4969. PubMed ID: 29049163 [Abstract] [Full Text] [Related]
39. Association of Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Gene Variants with Ischemic Stroke and Its Subtype. Huang XY, Han LY, Huang XD, Guan CH, Mao XL, Ye ZS. J Stroke Cerebrovasc Dis; 2017 Feb 15; 26(2):368-375. PubMed ID: 27793533 [Abstract] [Full Text] [Related]
40. A functional polymorphism in MMP1 could influence osteomyelitis development. Montes AH, Valle-Garay E, Alvarez V, Pevida M, García Pérez E, Paz J, Meana A, Asensi V. J Bone Miner Res; 2010 Apr 15; 25(4):912-9. PubMed ID: 19821768 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]